Go Pro
OTCMKTS:CVALF

Covalon Technologies (CVALF) Stock Price, News & Analysis

Covalon Technologies logo
$2.95 -0.25 (-7.70%)
As of 09/29/2026 02:45 PM Eastern

About Covalon Technologies Stock (OTCMKTS:CVALF)

Advanced

Key Stats

Today's Range
$2.87
▼
$3.65
50-Day Range
$1.52
▼
$3.20
52-Week Range
$1.16
▼
$3.65
Volume
31,838 shs
Average Volume
31,935 shs
Market Capitalization
$81.55 million
P/E Ratio
26.84
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Covalon Technologies Ltd. is a Canadian medical technology company focused on developing and commercializing advanced healthcare products. Its activities center on wound care, infection prevention and surgical applications, with technologies designed to help protect tissue, support healing and improve the management of medical procedures.

The company’s product portfolio includes collagen-based wound care products marketed under the ColActive brand, as well as antimicrobial and protective coatings, dressings and other medical devices. Covalon develops technologies for use in hospitals, clinics and other healthcare settings, including products intended to address chronic wounds, surgical wounds and infection-control needs.

Covalon serves healthcare providers and patients through commercial relationships with distributors and medical organizations in North America and selected international markets. The company is headquartered in Canada and has historically operated as a publicly traded healthcare technology business under the Covalon name.

AI Generated. May Contain Errors.

Receive CVALF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CVALF Stock News Headlines

Covalon Reports Fiscal 2026 Third Quarter Results
Covalon Technologies Ltd CVALF
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
Covalon Reports 2026 Second Quarter Results
See More Headlines

CVALF Stock Analysis - Frequently Asked Questions

Covalon Technologies' stock was trading at $1.25 at the beginning of 2026. Since then, CVALF shares have increased by 136.2% and is now trading at $2.9525.

Covalon Technologies Ltd. (OTCMKTS:CVALF) posted its earnings results on Thursday, August, 27th. The company reported $0.07 earnings per share for the quarter, beating analysts' consensus estimates of $0.01 by $0.06. The company had revenue of $7.07 million for the quarter, compared to analysts' expectations of $6.65 million. Covalon Technologies had a trailing twelve-month return on equity of 15.11% and a net margin of 12.77%.

Shares of CVALF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/27/2026
Today
9/29/2026
Fiscal Year End
9/30/2026
Next Earnings (Estimated)
12/10/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:CVALF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.11
Trailing P/E Ratio
26.84
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1.47 million
Net Margins
12.77%
Pretax Margin
12.79%
Return on Equity
15.11%
Return on Assets
12.71%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.56
Quick Ratio
6.62

Sales & Book Value

Annual Sales
$23.43 million
Price / Sales
3.48
Cash Flow
$0.07 per share
Price / Cash Flow
40.74
Book Value
$0.80 per share
Price / Book
3.69

Miscellaneous

Outstanding Shares
27,620,000
Free Float
N/A
Market Cap
$81.55 million
Optionable
Not Optionable
Beta
0.64
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (OTCMKTS:CVALF) was last updated on 9/30/2026 by MarketBeat.com Staff.
From Our Partners